Long-term study of EB-1020 for adults with ADHD
Treatments studied
Part of Mental health clinical trials.
This trial is for adults with ADHD who completed a previous study of the drug EB-1020. It tests the long-term safety and effectiveness of the medication over an extended period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed the earlier EB-1020 study and its follow-up period.
- You cannot be pregnant, breastfeeding, or planning to become pregnant during the trial.
- You must not have started any new ADHD medications or treatments since the end of the earlier study.
- You must not have serious thoughts of suicide or have attempted suicide in the recent past.
- You must not have had a severe side effect related to EB-1020 in the earlier study.
- You must test negative for drugs or alcohol at the start of the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called EB-1020 for adults with ADHD. It aims to see if the drug is safe and effective in improving ADHD symptoms. You may be able to join if you have a clear ADHD diagnosis and your symptoms are moderate to severe.
This trial tests a new medication, EB-1020, over a longer period in children with ADHD. It aims to see if the drug continues to be safe and effective beyond the initial 6-week treatment. Some participants may have already been in a previous EB-1020 study, while others are new.
This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.
This trial tests starting a new medication (Methylphenidate or Guanfacine) in young children with moderate or severe ADHD to see how well it works and if it’s safe.
This trial tests a study medication (dexamfetamine) for adults who have both ADHD and moderate to severe depression. It aims to see if the medication is safe and helps improve both conditions.
This trial tests if a mixed amphetamine medication helps teenagers with both autism and ADHD who still have significant symptoms, even if they are already on other treatments. It also includes typically developing teens as a comparison group.
Hear when a new Attention Deficit Hyperactivity Disorder (ADHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.